# Care Engagement Frequency, Disease Duration, and Socioeconomic Stratification as Determinants of Lower Extremity Amputation Risk in Diabetic Cohorts: A Framework for Retrospective EHR Analysis

*Pearl Research Engine — April 09, 2026*
*Focus: Users asked about 'Retrospective EHR cohort analysis stratifying diabetic patients who underwent LEA 2018-2023 by: (1) age band in 5-year increments, (2) diabetes duration at LEA date, (3) annual foot check frequency in the 24 months pre-LEA, (4) HbA1c measurement frequency in the 24 months pre-LEA, (5) SES proxy (zip-code ADI score), (6) COVID period (pre/during/post). Primary analysis: Cox regression with care engagement frequency × COVID period interaction term, controlling for disease duration and SES. Secondary analysis: decompose the 45-64 band into disease duration quartiles to test whether age band effect disappears when disease duration is accounted for.' but Pearl couldn't ground the answer*
*Confidence: low*

---

# Care Engagement Frequency, Disease Duration, and Socioeconomic Stratification as Determinants of Lower Extremity Amputation Risk in Diabetic Cohorts: A Hypothesis-Generation Framework

## Abstract

This document synthesizes available evidence and structural analogies to generate testable hypotheses for a retrospective EHR cohort analysis examining lower extremity amputation (LEA) rates in diabetic patients from 2018-2023. The proposed study design — stratifying by age band, diabetes duration, pre-LEA care engagement frequency, HbA1c monitoring frequency, socioeconomic status (ADI score), and COVID period — addresses a genuine knowledge gap at the intersection of healthcare systems research, diabetology, and health equity. Pearl's knowledge base contains no direct evidence for this specific domain; the 10 retrieved evidence pieces span unrelated conditions (ERCP pancreatitis, cerebrovascular morphology, colorectal cancer, EGFR resistance, Parkinson's ICB, IBS, hypophosphatasia, ASD music therapy, respiratory virome). Despite this mismatch, structural and methodological analogies yield three competing hypotheses with testable predictions. The primary evolved insight is that nonlinear threshold effects in care continuity — best revealed by the COVID natural experiment — likely dominate the risk landscape more than linear dose-response models would suggest. Confidence is appropriately low given the absence of direct evidence, and the document should be treated as a research design scaffold rather than a synthesized conclusion.

---

## Evidence Review

### Available Evidence and Its Relevance

The 10 retrieved evidence pieces are assessed for structural relevance to the LEA cohort analysis question:

**High structural relevance (methodological analogues):**

1. **Colorectal Cancer Screening (decoded-7e22d8926a24)**: This study's core finding — that intention-to-screen analysis reveals true risk reductions (31% at 8 years) substantially exceeding apparent reductions (16%) — provides the most methodologically important analogue. The divergence occurs because standard observational analysis attributes risk to the non-screened group without accounting for compliance drift in the screened group. For LEA analysis, this implies that observed associations between foot check frequency and LEA risk will likely *underestimate* true protective effects, because the "high-engagement" group in EHR data contains patients who attended some but not all recommended visits. A true-vs-apparent protective effect calculation should be built into the secondary analysis.

2. **Cerebrovascular Risk Stratification (decoded-8389d04a6bc8)**: The demonstration that automated, scalable EHR-integrated morphological analysis captures physiologically fundamental determinants not visible in standard clinical assessment validates the proposed multi-dimensional stratification approach. The key methodological lesson: composite stratification (age + duration + engagement frequency + SES + COVID period) should reveal risk patterns invisible to any single-variable analysis.

**Moderate structural relevance (biological mechanism analogues):**

3. **miR-451 and Fracture Healing (decoded-65a18476aab1)**: miR-451's regulation of osteogenesis and mineralization in hypophosphatasia patients provides a micro-level parallel: disease-specific molecular dysregulation impairs tissue repair in a duration-dependent manner. In diabetic feet, analogous molecular changes (advanced glycation end-products, microvascular basement membrane thickening, neuropathy-related loss of protective sensation) accumulate with disease duration and impair wound healing — the cellular-level mechanism underlying the macroscopic LEA risk trajectory.

4. **Alpha-Synuclein and Nonlinear Phenotype (decoded-950af3accfbf)**: The finding that alpha-synuclein deposition in the nucleus accumbens is *lower* in ICB patients than non-ICB patients demonstrates that biological burden does not map linearly to clinical phenotype. This is a critical caution for the Cox regression design: HbA1c values and foot check frequency may have nonlinear, threshold-dependent relationships with LEA risk rather than monotonic dose-response curves. Restricted cubic splines should be used rather than linear terms.

5. **COVID Virome Disruption (GRK-defense-respiratory-virome)**: COVID-era disruption to established biological/ecological equilibria produced cascade effects (viral diversity expansion, immune remodeling) that exceeded linear predictions. By structural analogy, COVID-era disruption to care engagement rhythms may produce nonlinear LEA risk elevations in previously well-managed patients — the system transitions to a new risk attractor state when the stabilizing feedback loop (regular care engagement) is interrupted.

**Low direct relevance (included for completeness):**
- ERCP pancreatitis mechanism, EGFR-TKI resistance, FODMAP IBS mechanism, ASD music therapy: no meaningful structural connection to LEA risk in diabetic cohorts.

### Critical Evidence Gaps

The knowledge base contains no entries on:
- Diabetic foot ulcer epidemiology or natural history
- LEA rates, trends, or risk factors
- The effect of COVID-19 on diabetes management or complications
- Care engagement metrics as predictors of diabetic outcomes
- ADI (Area Deprivation Index) as an SES proxy in any context
- HbA1c monitoring frequency and glycemic control outcomes
- Healthcare utilization patterns in diabetic populations

This represents a genuine and substantial knowledge gap. The hypotheses generated below are explicitly scaffolded on structural analogies and first principles, not on direct evidence.

---

## Hypothesis Generation

### Hypothesis A: SES-Moderated Care Engagement Effect (Conservative/Tier 1)

**Claim**: Care engagement frequency (foot check and HbA1c measurement rate in the 24 months pre-LEA) is an independent negative predictor of LEA risk. This effect is moderated by SES (ADI score), such that high-deprivation patients show greater marginal benefit per additional care visit — a pattern consistent with the steeper risk gradients seen in underserved populations. The COVID period amplifies this by differentially reducing care access across SES strata.

**Analytical Framework**: 
- *Control theory*: Regular foot checks and HbA1c monitoring constitute a negative feedback control system — deviations from glycemic setpoints and early wound detection allow corrective intervention before LEA threshold is crossed. COVID disrupts this feedback loop's gain.
- *Network theory*: The healthcare engagement network (patient → PCP → podiatrist → wound care) has bottlenecks in high-deprivation communities. COVID's stress on the network disproportionately breaks connections at these bottlenecks.
- *Information theory*: Each foot check generates clinical information (ulcer presence, sensation assessment, vascular status). Reduced check frequency = information starvation of the care system, leading to late detection.

**Primary Prediction**: Cox regression will show significant main effects for foot check frequency (HR <1.0), ADI score (HR >1.0), and a significant ADI × foot check interaction, with the interaction term reflecting greater protective effect of engagement in high-deprivation areas.

**Falsification Criterion**: Non-significant interaction term (p>0.10) after robust standard error adjustment, or evidence that high-deprivation patients actually show *less* benefit per foot check (suggesting access quality differences override quantity effects).

---

### Hypothesis B: Disease Duration as the Dominant Confounder of Age-Band Effects (Integrative/Tier 2)

**Claim**: The apparent elevation of LEA risk in the 45-64 age band is primarily a disease duration artifact. Patients undergoing LEA at ages 45-64 are disproportionately those who developed type 2 diabetes in their late 20s-30s during the obesity epidemic acceleration of the 1990s-2000s, giving them 15-25 years of cumulative disease burden. When disease duration quartiles are introduced as covariates within this age band (secondary analysis), the age coefficient attenuates substantially, and disease duration emerges as the primary time-varying predictor.

**Analytical Framework**:
- *Fractals*: Disease duration-dependent risk accumulation is self-similar across scales — at the cellular level (glycation end-product accumulation, progressive microvascular basement membrane thickening), at the organ level (peripheral neuropathy severity, retinopathy progression), and at the population level (cohort-specific LEA rate elevation).
- *Phase transitions*: After 15-20 years of type 2 diabetes, the disease crosses a clinical threshold where multiple complications co-occur (neuropathy + vasculopathy + impaired wound healing), producing a phase transition in LEA risk that correlates with the age distribution of the 45-64 band.
- *Chaos attractors*: The diabetic foot represents a bistable system — either in a managed/low-risk attractor state or a progressive-complications/high-risk attractor. Disease duration gradually destabilizes the low-risk state.

**Critical Methodological Note**: The secondary analysis must stratify by diabetes type (1 vs. 2) before decomposing by duration quartile, as type 1 patients in the 45-64 band may have 40+ years of disease duration compared to 5-15 years for type 2 patients in the same band — conflating these produces spurious duration estimates.

**Falsification Criterion**: If the age-band coefficient for the 45-64 group remains significant (p<0.05) after adjustment for disease duration quartile within diabetes type strata, the confounding hypothesis fails. Alternatively, if type 1 and type 2 patients show identical duration-quartile risk profiles within the 45-64 band despite dramatically different duration distributions.

---

### Hypothesis C: Care Continuity Threshold and COVID Bifurcation (Radical/Tier 3)

**Claim**: The relationship between care engagement frequency and LEA risk is not linear but threshold-dependent. There exists a critical care engagement frequency (hypothesized: approximately 1 annual foot check per 12 months) below which the system transitions nonlinearly to a high-risk attractor state. The COVID-era natural experiment will reveal this threshold more clearly than any designed study: patients with high pre-COVID engagement who experienced COVID-era disengagement below the threshold will show disproportionately elevated LEA rates compared to chronically low-engagement patients, who show smaller COVID-era increments because they were already near the high-risk attractor.

**Analytical Framework**:
- *Chaos attractors*: The bistable foot health system has a separatrix — a threshold engagement frequency that separates the managed-state basin from the high-risk-state basin. COVID-induced disengagement pushes previously well-managed patients across this separatrix.
- *Phase transitions*: The COVID period represents a system-level perturbation that reveals bifurcation points invisible in gradual, linear analyses.
- *Coupled oscillators*: Regular care visits constitute an entrained rhythm (patient-provider engagement cycle) whose disruption causes desynchronization with the body's own wound-detection and repair rhythms. COVID disrupts this entrainment, and the consequences are nonlinear.

**Prediction**: Interaction terms between COVID period (during/post vs. pre) and care engagement frequency will show significant nonlinearity when modeled with splines. High-engagement pre-COVID patients who dropped below the threshold during COVID will show the largest LEA risk elevation — larger than what their absolute engagement frequency during COVID would linearly predict.

**Falsification Criterion**: Spline analysis shows no evidence of nonlinearity (all confidence bands encompass a linear fit); or the COVID × engagement interaction is monotonically linear without evidence of inflection.

---

## Debate and Objections

### Against Hypothesis A

**Healthy Engager Bias**: The most serious threat. Patients who attend regular foot checks differ systematically from non-attenders on unmeasured variables: health literacy, social support networks, transportation access, employment flexibility, and intrinsic health motivation. ADI score and disease duration partially adjust for this, but EHR data cannot fully capture these dimensions. The observed SES × engagement interaction might reflect residual confounding rather than true effect modification — high-SES patients who engage get residual-confounder benefits, not just the care itself.

**Counterargument**: The colorectal screening literature provides a template for bounding this bias. If researchers compute both per-protocol estimates and intention-to-treat-equivalent estimates (using baseline-predicted engagement as the treatment variable), the gap between estimates quantifies the healthy engager bias magnitude. A study that explicitly reports both estimates advances the field even if the true causal effect remains uncertain.

### Against Hypothesis B

**Type 1/Type 2 Conflation**: As noted, the 45-64 age band contains a heterogeneous mixture. More critically, some EHR systems code diabetes type inconsistently (particularly for LADA and atypical presentations). If the secondary analysis cannot reliably separate type 1 from type 2, the duration-quartile decomposition may be contaminated.

**Counterargument**: Even with imperfect diabetes type coding, insulin use at diagnosis (available in most EHR systems) provides a reasonable proxy distinguisher. Sensitivity analyses using insulin-at-diagnosis as an alternative stratifier can bound the impact of misclassification.

### Against Hypothesis C

**COVID Confounding Complexity**: The COVID period simultaneously: (a) reduced in-person visits, (b) expanded telehealth (potentially compensating), (c) caused economic disruption affecting SES independently, (d) differentially removed highest-risk patients from the cohort via COVID mortality before LEA could occur (survival bias), and (e) disrupted supply chains for wound care products. Attributing a bifurcation pattern specifically to care engagement disruption requires modeling all these simultaneously — likely beyond what EHR data can support without linked administrative and mortality data.

**Counterargument**: The COVID mortality survival bias actually makes the nonlinear effect hypothesis *more* conservative — the highest-risk patients who died of COVID before reaching LEA would have inflated the LEA rate, so removing them from the cohort biases against finding elevated LEA rates during COVID. If the bifurcation pattern is observed despite this anti-conservative bias, it strengthens the hypothesis.

---

## Synthesis and Evolved Insight

Integrating across all three hypotheses and their objections, the most defensible evolved position is:

**Core Claim**: The proposed Cox regression analysis should be designed with explicit nonlinearity testing as its primary methodological innovation, not the interaction term per se. The interaction term (care engagement × COVID period) is methodologically correct, but framing it as a linear-by-linear interaction misses the most important signal — whether COVID-era disruption reveals a threshold effect in care continuity.

**Design Recommendations**:

1. **Replace linear care engagement term with restricted cubic splines** (4-5 knots) before specifying any interaction, to test the linearity assumption and identify potential threshold locations.

2. **Add diabetes type stratification** as a prerequisite for the secondary analysis decomposing the 45-64 band into duration quartiles. Without this, the secondary analysis conflates type 1 and type 2 natural histories.

3. **Compute true vs. apparent protective effects** in the style of the colorectal screening literature — compare per-protocol estimates (actually high-engagement patients) to intention-to-treat-equivalent estimates (baseline-predicted high-engagement patients) to bound healthy engager bias.

4. **Include telehealth visit coding** as a component of care engagement frequency, not just in-person visits. COVID-era telehealth may have substantially compensated for lost in-person visits in some systems/populations but not others — this heterogeneity is scientifically important.

5. **Link to vital statistics data** to adjust for COVID mortality survival bias — patients who died of COVID before potential LEA date should be censored at death, not at study end, using cause-of-death ICD codes.

**Confidence**: Low. No direct evidence from Pearl's knowledge base supports these specific claims. The structural analogies are plausible and the methodological recommendations are sound, but the empirical predictions remain untested hypotheses.

---

## Implications

If Hypothesis A is confirmed: Policy intervention should target care engagement frequency in high-deprivation communities, with the marginal benefit per visit being greatest precisely where visits are hardest to achieve. This argues for mobile podiatry services, community health worker-mediated foot check programs, and telehealth expansion specifically in high-ADI zip codes.

If Hypothesis B is confirmed: Age-based screening cutoffs for intensive diabetic foot surveillance should be replaced by disease-duration-based cutoffs. A 52-year-old with 20 years of type 2 diabetes needs more intensive monitoring than a 60-year-old with 5 years of disease — the current clinical default of age-based risk stratification systematically misallocates resources.

If Hypothesis C is confirmed: Healthcare systems should build care continuity resilience into their disaster preparedness frameworks. The COVID natural experiment would demonstrate that even well-managed chronic disease patients reach a catastrophic tipping point when care rhythms are disrupted below a threshold — a finding with implications for any future system-level disruption (pandemics, natural disasters, workforce strikes).

---

## Open Questions

1. What is the minimum annual foot check frequency that constitutes a protective threshold? Is it 1, 2, or 4 per year? Does it differ by disease duration quartile?

2. Does the COVID interaction effect differ between urban health systems with rapid telehealth adoption and rural systems with limited telehealth infrastructure?

3. How does diabetes type modify the disease-duration quartile effect within the 45-64 age band? Do type 1 patients show duration-dependent risk even in the longest-duration quartile (suggesting a plateau), while type 2 patients show monotonically increasing risk?

4. What is the lag time between care disengagement and LEA? Does the risk accumulate gradually (linear model) or suddenly (threshold model), and can the EHR time-series data distinguish between these?

5. Are there racial/ethnic interaction effects with ADI score that the zip-code-level proxy fails to capture? Zip codes are ecological measures that may mask within-zip-code racial segregation and differential access.

6. What soul-level and spirit-level factors — patient sense of meaning around their body, cultural beliefs about amputation and body integrity, trust in healthcare systems, chronic grief around progressive disability — mediate the SES effect on care engagement? Can any be proxied in structured EHR fields (e.g., advance directive completion as a proxy for engagement with health planning, or chaplaincy referrals as a proxy for spiritual distress)?

7. Does the ADI score from the LEA date zip code reflect the patient's SES throughout the disease duration, or only at LEA time? Residential mobility in low-SES populations may mean that LEA-date ADI systematically underestimates lifetime SES disadvantage.

8. How should researchers handle the competing risk of death before LEA? Standard Cox regression may be inappropriate if COVID mortality differentially removes high-risk patients from the cohort — cause-specific hazard models or Fine-Gray subdistribution hazard models may be necessary.

---

*Document generated by Pearl's Research Mind. All hypotheses are candidates for Judge evaluation. No conclusions are drawn. Confidence: Low, reflecting absence of direct evidence in Pearl's knowledge base for this research domain.*